Mackay Shields LLC Abiomed Inc Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$224.73 - $338.64 $1.46 Million - $2.21 Million	-6,513 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$277.25 - $366.29 $69,589 - $91,938	-251 Reduced 3.71%	6,513 $2.16 Million
Q4 2021 Feb 04, 2022	SELL	$300.63 - $371.35 $37,578 - $46,418	-125 Reduced 1.81%	6,764 $2.43 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $62,348 - $75,616	-201 Reduced 2.83%	6,889 $2.24 Million
Q2 2021 Aug 13, 2021	SELL	$262.71 - $351.17 $104,558 - $139,765	-398 Reduced 5.32%	7,090 $2.21 Million
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $14,010 - $17,401	-49 Reduced 0.65%	7,488 $2.39 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $14,860 - $19,127	59 Added 0.79%	7,537 $2.44 Million
Q3 2020 Nov 04, 2020	BUY	$255.22 - $317.0 $57,934 - $71,959	227 Added 3.13%	7,478 $2.07 Million
Q2 2020 Jul 31, 2020	BUY	$141.4 - $257.09 $34,218 - $62,215	242 Added 3.45%	7,251 $1.75 Million
Q1 2020 May 08, 2020	SELL	$130.51 - $196.01 $4,437 - $6,664	-34 Reduced 0.48%	7,009 $1.02 Million
Q4 2019 Feb 11, 2020	SELL	$159.31 - $223.54 $68,662 - $96,345	-431 Reduced 5.77%	7,043 $1.2 Million
Q3 2019 Nov 01, 2019	SELL	$175.89 - $279.23 $2.25 Million - $3.57 Million	-12,781 Reduced 63.1%	7,474 $1.33 Million
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $109,920 - $124,803	-438 Reduced 2.12%	20,255 $5.28 Million
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $63,569 - $83,317	-230 Reduced 1.1%	20,693 $5.91 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $5.88 Million - $9.3 Million	20,923 New	20,923 $6.8 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $6.67 Million - $8.46 Million	-18,820 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$278.07 - $446.21 $5.23 Million - $8.4 Million	18,820 New	18,820 $7.7 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account